SCHEMBL16334818

SCHEMBL16334818

COc1cc(OC)c2c(=O)c(-c3ccc(OC)c(O)c3)coc2c1

nearest known ligand 0.75

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 5/20 0.75
▸ CYP3A4 P08684 4/20 0.75
▸ ALDH1A1 P00352 3/20 0.75
▸ HSD17B10 Q99714 3/20 0.75
▸ NPC1 O15118 3/20 0.75
▸ RAB9A P51151 3/20 0.75
▸ SMN1; SMN2 Q16637 4/20 0.70
▸ MAPT P10636 3/20 0.70
▸ TP53 P04637 2/20 0.70
▸ THRB P10828 1/20 0.70
▸ HPGD P15428 1/20 0.70
▸ MEN1 O00255 1/20 0.66
▸ CYP1A2 P05177 1/20 0.66
▸ CYP2D6 P10635 1/20 0.66
▸ CYP2C9 P11712 1/20 0.66
▸ NFKB1 P19838 1/20 0.66
▸ CYP2C19 P33261 1/20 0.66
▸ NFKB2 Q00653 1/20 0.66
▸ KMT2A Q03164 1/20 0.66
▸ RELA Q04206 1/20 0.66

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16335756 0.93 CYP3A4 (0.75) KDM4ECYP3A4ALDH1A1HSD17B10NPC1
SCHEMBL16389392 0.90 CYP3A4 (0.75) KDM4ECYP3A4ALDH1A1HSD17B10NPC1
SCHEMBL30288208 0.89 CYP3A4 (0.81) KDM4ECYP3A4ALDH1A1HSD17B10NPC1
SCHEMBL28788159 0.88 KDM4E (0.83) KDM4ECYP3A4ALDH1A1HSD17B10NPC1
SCHEMBL27757185 0.88 CYP3A4 (0.70) KDM4ECYP3A4ALDH1A1HSD17B10NPC1
SCHEMBL16389295 0.86 RAB9A (0.55) KDM4ECYP3A4ALDH1A1HSD17B10NPC1
Biochanin A, Dimethyl Ether SCHEMBL5795557 0.86 CYP3A4 (1.00) KDM4ECYP3A4ALDH1A1HSD17B10NPC1
SCHEMBL18324965 0.85 KDM4E (0.62) KDM4ECYP3A4ALDH1A1HSD17B10NPC1
Pratensein SCHEMBL29349666 0.84 RAB9A (0.73) KDM4ECYP3A4ALDH1A1HSD17B10NPC1
Pratensein SCHEMBL73557 0.84 RAB9A (0.73) KDM4ECYP3A4ALDH1A1HSD17B10NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3013331-B1 MULTITARGET HEDGEHOG PATHWAY INHIBITORS AND THEIR USE FOR THE TREATMENT OF CERTAIN HEDGEHOG (HH)-DEPENDENT TUMORS UNIV DEGLI STUDI DI SIENA (IT) 2023-03-01 — — EP disclosed
US-10093642-B2 Multitarget hedgehog pathway inhibitors and uses thereof Università degli Studi di Roma “La Sapienza” (IT) 2018-10-09 — — US disclosed
US-20160368886-A1 MULTITARGET HEDGEHOG PATHWAY INHIBITORS AND USES THEREOF UNIVERSITA' DEGLI STUDI DI SIENA (IT) 2016-12-22 — — US disclosed
US-20160368886-A1 MULTITARGET HEDGEHOG PATHWAY INHIBITORS AND USES THEREOF UNIVERSITA' DEGLI STUDI DI SIENA (IT) 2016-12-22 — — US disclosed
EP-3013331-A1 MULTITARGET HEDGEHOG PATHWAY INHIBITORS AND USES THEREOF Università degli Studi di Siena (IT) 2016-05-04 — — EP disclosed
WO-2014207069-A1 MULTITARGET HEDGEHOG PATHWAY INHIBITORS AND USES THEREOF UNIVERSITA' DEGLI STUDI DI SIENA (IT) 2014-12-31 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160368886-A1 MULTITARGET HEDGEHOG PATHWAY INHIBITORS AND USES THEREOF SHH, GLI1, SMO KDM4E 942/4885CYP3A4 4845/4885ALDH1A1 2823/4885
US-10093642-B2 Multitarget hedgehog pathway inhibitors and uses thereof SHH, GLI1, SMO KDM4E 942/4885CYP3A4 4845/4885ALDH1A1 2823/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback